Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Premium Report
|
This report provides an analytical summary of the pharmaceutical market in Spain including socioeconomic and demographic trends, regulatory issues, generics and biosimilars, and pharmaceutical market and pharmaceutical company infrastructure.
Published By Scrip Insights
|
26 Oct 2012 |
$1900
|
Premium Report
|
Pharma companies are increasingly competing on their ability to successfully launch products and manage the lifecycle of their products. The report reviews lessons from 10 case studies of launches.
Published By Scrip Insights
|
19 Oct 2012 |
$1910
|
Premium Report
|
Micro and nanotechnologies are set to transform point-of-care diagnostics. Miniaturization of testing methods, advances in lab-on-a-chip microfluidic methodologies, improvements in detection technologies and novel biosensors are leading the way.
Published By Scrip Insights
|
15 Oct 2012 |
$1910
|
Premium Report
|
High Phase II attrition is hampering the pharma industry’s ability to reach sustainable rates of innovation. More rigorous validation of new biological targets prior to clinical development is essential for increasing R&D efficiency.
Published By Scrip Insights
|
28 Sep 2012 |
$2875
|
Premium Report
|
A summary of the main diversification strategies used by pharma companies, in addition to the merger, acquisition, and divestment history of the top 10 companies, which have been instrumental in shaping the industry’s current business model.
Published By Scrip Insights
|
28 Sep 2012 |
$1910
|
Premium Report
|
This report provides an analytical summary of the pharmaceutical market in Brazil including socioeconomic and demographic trends, regulatory issues, generics and biosimilars, and pharmaceutical market and pharmaceutical company infrastructure.
Published By Scrip Insights
|
27 Sep 2012 |
$1910
|
Premium Report
|
CNS drugs are associated with longer development times and higher attrition rates than drugs for other therapy areas. Advances in delivery technologies are essential if the pursuit of novel treatments is to remain commercially viable.
Published By Scrip Insights
|
31 Aug 2012 |
$2875
|
Premium Report
|
Favorable legislation and recent commercial successes have stimulated growing interest in the discovery of novel orphan drugs. However, there are many strategic considerations that are peculiar to the R&D process for diseases of low prevalence.
Published By Scrip Insights
|
28 Aug 2012 |
$2875
|
Premium Report
|
Comparative efficacy data are not necessarily required for approval but are increasingly demanded by payers. Meeting the expectations of all stakeholders can be challenging, making comparator selection and trial design complex decisions.
Published By Scrip Insights
|
06 Aug 2012 |
$2875
|
Premium Report
|
Industry pressures are impacting on both pharma sponsors and CROs, prompting them to evolve the way they contract and engage. Outsourced R&D also increasingly spans the full range of the value chain creating a developing market for contract services.
Published By Scrip Insights
|
18 Jul 2012 |
$2875
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.